Veterinary Immunodiagnostics Market Anticipated to Hit $2.71 Billion by 2029

Meticulous Research®—a leading global market research company, published a research report titled, Veterinary Immunodiagnostics Market by Product (Analyzers, Consumables {Leukemia, Influenza, BTV, FMD, BTB, BHV}), Animal (Livestock, Companion), Technology (ELISA, Radioimmunoassay, Rapid Tests), End User (Hospitals, Point of care)—Global Forecast to 2029.’

Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=2897?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

According to the latest publication by Meticulous Research®, the global veterinary immunodiagnostics market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.3% from 2022, reaching $2.71 billion by 2029. This growth is attributed to the increasing prevalence of animal diseases, advancements in immunodiagnostic testing technologies, and the rising availability of specialized diagnostic solutions. The expanding pet population and higher demand for animal-based products are further driving market expansion. However, the lack of diagnostic infrastructure in developing regions remains a significant barrier.

The market is segmented by Product (Analyzers, Consumables), Animal Type (Companion Animals, Livestock), Technology (ELISA, Radioimmunoassay, Rapid Tests, Others), End User (Reference Laboratories, Veterinary Hospitals & Clinics, Point of Care Testing), and Geography, allowing for a comprehensive analysis of market trends and competition. In 2022, the consumables segment is expected to dominate, driven by their precision, affordability, and widespread use in disease-specific tests. ELISA technology is projected to hold the largest market share, propelled by innovation in biomarkers and increased adoption of automated platforms.

The livestock segment is forecasted to capture the largest market share in 2022 due to the rising demand for food production and greater focus on animal health. Reference laboratories are expected to lead in terms of market share, owing to the growing trend of outsourcing diagnostic services. Geographically, North America is set to remain the largest market, followed by Europe and Asia-Pacific, due to well-established infrastructure and significant investment in veterinary care.

Prominent companies in the market include IDEXX Laboratories, Inc., Zoetis Inc., Thermo Fisher Scientific Inc., Virbac, Heska Corporation, Randox Laboratories Ltd., Neogen Corporation, QIAGEN N.V., Abaxis, Inc., and bioMérieux S.A

Buy Now@ https://www.meticulousresearch.com/Checkout/68519300?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=17-09-2024

About Meticulous Research®:

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

 

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Comments on “Veterinary Immunodiagnostics Market Anticipated to Hit $2.71 Billion by 2029”

Leave a Reply

Gravatar